The effect of computerised cognitive training on cognitive impairments in breast cancer patients - Clinical trial • Breast Cancer Foundation NZ

The effect of computerised cognitive training on cognitive impairments in breast cancer patients

Recruiting
Updated: June 30, 2020

This study aims to assess the impact of a computerised cognitive training program on the neurotoxic effects of chemotherapy on cognition in breast cancer patients.

This study aims to assess the impact of a computerised cognitive training program on the neurotoxic effects of chemotherapy on cognition in breast cancer patients.

Who is it for?

You may be eligible to participate in this study if you are aged 21 years or older, have been diagnosed with Stage I-III breast cancer and are scheduled to receive chemotherapy treatment.

Study details

Participants will be randomly assigned (by chance) to receive either the computerised cognitive training program, or continue with standard care. Those in the computerised cognitive training group will undergo three 45-minute sessions for the duration of their chemotherapy (minimum of 18 weeks). The standard care group will be provided with details of the computerised cognitive training program. All participants will undertake a series of clinical assessments, including cognitive, mood, sleep, physical activity, quality of life tests and questionnaires.

It is hoped this research will inform the treatment of breast cancer patients presenting with detrimental cognitive changes as a result of chemotherapy, and this research may lead to better quality of life for patients.

Full trial information

Australia

Fiona Stanley Hospital, Melbourne
Sir Charles Gairdner Hospital, Perth
St John of God Hospital, Perth

Contact:

Travis Cruickshank

If you think you might be a candidate for this trial, use the contact details supplied, or talk to your doctor.

Want to access a trial that's not in your area? It's not always possible, but if you're interested, email us at intouch@bcf.org.nz

Similar clinical trials

For Early Breast Cancer

  • Observation Toxicity Study
    Updated: January 20, 2022
    Recruiting
    New Zealand
    This is an observational cohort study of toxicity in female patients treated for early breast cancer with Adriamycin and Cyclophosphamide chemotherapy.
    More details

  • Prescribed Exercise
    Updated: January 20, 2022
    Recruiting
    New Zealand
    This study is assessing the benefits of prescribed exercise in clinical populations, including people with breast cancer.
    More details

  • SAND
    Updated: January 20, 2022
    Recruiting
    New Zealand
    This study aims to reduce inflammation in post-menopausal women with breast cancer through the use of asprin.
    More details

Are we out of date? If you have updated or new information about a trial, we’d be grateful if you’d share it with us – email your update to intouch@bcf.org.nz

Find clinical trials

Interested in a clinical trial?

Subscribe for updates & stay in the loop with new studies.